Xiao Hong Chen

3PUBLICATIONS
4CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 21, 2021
FDA Approval Summary: Tivozanib for Relapsed or Refractory Renal Cell Carcinoma.

Elaine Chang, Chana Weinstock, Lijun Zhang

|Oct 15, 2020
FDA Approval Summary: Tucatinib for the Treatment of Patients with Advanced or Metastatic HER2-positive Breast Cancer.

Mirat Shah, Suparna Wedam, Joyce Cheng

Pageof 1

Frequent Collaborators

3 joint publications

Kirsten B Goldberg

2 joint publications

Suparna Wedam

1 joint publications

Elaine Chang

1 joint publications

Amna Ibrahim